AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $198.05
-
Support level$196.59
-
Resistance levelN/A
-
Beta0.4
-
RSI (14-day)73.3
- Volatility is forecast to fall over the next month.
- ABBV is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, ABBV is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $164.99 | $216.66 | 67.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $188.03 | $189.63 | $191.75 | $194.22 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week5.8%
-
In the next month12.8%
-
In the next year54.8%
| Period | Value |
|---|---|
| Historical (5 year) | 22.9% |
| Last month | 21.1% |
| Current estimate | 21.5% |
| Next month forecast | 22.6% |